Guo S - Search Results

1

A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification.

Zhu H, Wang C, Wang J, Chen D, Deng J, Deng J, Fan J, Badakhshi H, Huang X, Zhang L, Cai J, Guo S, Qian W, Nie Y, Li Q, Zhao K. Zhu H, et al. Among authors: guo s. J Thorac Dis. 2018 Sep;10(9):5328-5338. doi: 10.21037/jtd.2018.09.18. J Thorac Dis. 2018. PMID: 30416780 Free PMC article.

2

Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model.

Jiang J, Wang DD, Yang M, Chen D, Pang L, Guo S, Cai J, Wery JP, Li L, Li HQ, Lin PP. Jiang J, et al. Among authors: guo s. Oncotarget. 2015 Jun 20;6(17):15639-51. doi: 10.18632/oncotarget.3712. Oncotarget. 2015. PMID: 25909226 Free PMC article.

3

A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.

Chen D, Huang X, Cai J, Guo S, Qian W, Wery JP, Li QX. Chen D, et al. Among authors: guo s. Oncotarget. 2015 Dec 1;6(38):40815-21. doi: 10.18632/oncotarget.5886. Oncotarget. 2015. PMID: 26512781 Free PMC article.

4

Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines.

Guo S, Qian W, Cai J, Zhang L, Wery JP, Li QX. Guo S, et al. Cancer Res. 2016 Aug 15;76(16):4619-26. doi: 10.1158/0008-5472.CAN-15-3245. Epub 2016 Jun 20. Cancer Res. 2016. PMID: 27325646

5

Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature.

Guo S, Chen D, Huang X, Cai J, Wery JP, Li QX. Guo S, et al. Oncotarget. 2016 Aug 2;7(31):50575-50581. doi: 10.18632/oncotarget.10499. Oncotarget. 2016. PMID: 27409671 Free PMC article.

6

Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.

Hong B, Yang Y, Guo S, Duoerkun S, Deng X, Chen D, Yu S, Qian W, Li Q, Li Q, Gong K, Zhang N. Hong B, et al. Among authors: guo s. Oncotarget. 2017 Jul 25;8(30):49839-49850. doi: 10.18632/oncotarget.17765. Oncotarget. 2017. PMID: 28548943 Free PMC article.

7

The design, analysis and application of mouse clinical trials in oncology drug development.

Guo S, Jiang X, Mao B, Li QX. Guo S, et al. BMC Cancer. 2019 Jul 22;19(1):718. doi: 10.1186/s12885-019-5907-7. BMC Cancer. 2019. PMID: 31331301 Free PMC article.

8

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population.

Zhao Q, Xue J, Hong B, Qian W, Liu T, Fan B, Cai J, Ji Y, Liu J, Yang Y, Li Q, Guo S, Zhang N. Zhao Q, et al. Among authors: guo s. Cancer Cell Int. 2020 Sep 22;20:461. doi: 10.1186/s12935-020-01552-w. eCollection 2020. Cancer Cell Int. 2020. PMID: 32982583 Free PMC article.

9

Authentication, characterization and contamination detection of cell lines, xenografts and organoids by barcode deep NGS sequencing.

Chen X, Qian W, Song Z, Li QX, Guo S. Chen X, et al. Among authors: guo s. NAR Genom Bioinform. 2020 Aug 18;2(3):lqaa060. doi: 10.1093/nargab/lqaa060. eCollection 2020 Sep. NAR Genom Bioinform. 2020. PMID: 33575611 Free PMC article.

10

Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research.

Xu X, Shang L, Wang P, Zhou J, Ouyang X, Zheng M, Mao B, Zhang L, Chen B, Wang J, Chen J, Qian W, Guo S, Huang Y, Li QX. Xu X, et al. Among authors: guo s. J Vis Exp. 2021 May 5;(171). doi: 10.3791/61382. J Vis Exp. 2021. PMID: 34028430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,624 results

Search Page

Filters